New research presents a solution to a fundamental challenge: ensuring accurate glucose readings from wearable devices. Read more.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Glucose Monitoring Devices MarketAs the global burden of diabetes continues to grow, the need for accurate and efficient ...

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient ...

Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

A new consensus statement offers “considerations and good practice points” for the use of continuous glucose monitoring ...

Wearable electronic devices are potential tools to monitor blood glucose levels (BGLs) among people with diabetes, but their ...

Rollme has launched the X3 smartwatch, making a significant impact in the global market with its advanced health monitoring features at an affordable price. This smartwatch is particularly noted for ...

People are hungry for information about their bodies. Nearly one-third of Americans don smartwatches and other wearable technology to measure things such as step counts, calories burned and heart rate ...